News

Light & Wonder: Following Grover Acquisition Is Less Expensive (NASDAQ:LNW)

1 Mins read

This article was written by

I am an avid investor with a major focus on small cap companies with experience in investing in US, Canadian, and European markets. My investment philosophy to generating great returns on the stock market revolves around identifying mispriced securities by understanding the drivers behind a company’s financials, and ultimately, most often revealed by a DCF model valuation. This methodology doesn’t limit an investor into rigid traditional value, dividend, or growth investing, but rather accounts for all of a stock’s prospects to determine the risk-to-reward.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

EHI: Solid Global Income Fund, But Not Ideal Time For Entry (NYSE:EHI)

1 Mins read
This article was written by Follow Financial analyst by day and a seasoned investor by passion, I’ve been involved in the world…
News

NovoCure Stock: Loading Up On Growth Catalysts (NASDAQ:NVCR)

1 Mins read
This article was written by Follow Biologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies…
News

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON)

1 Mins read
This article was written by Follow My handle is the Michigan Value Investor, but everyone calls me MVI. I have a PhD…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *